| Primary |
| Depression |
26.0% |
| Drug Use For Unknown Indication |
15.6% |
| Obsessive-compulsive Disorder |
14.8% |
| Product Used For Unknown Indication |
11.2% |
| Ill-defined Disorder |
5.9% |
| Social Phobia |
3.1% |
| Drug Exposure During Pregnancy |
2.8% |
| Insomnia |
2.5% |
| Anxiety |
2.2% |
| Decreased Appetite |
2.2% |
| Hallucination |
2.2% |
| Major Depression |
1.7% |
| Pain |
1.7% |
| Accidental Exposure |
1.4% |
| Pyrexia |
1.4% |
| Schizophrenia |
1.4% |
| Maternal Exposure Timing Unspecified |
1.1% |
| Small Cell Lung Cancer |
1.1% |
| Acute Promyelocytic Leukaemia |
0.8% |
| Psychotic Disorder |
0.8% |
|
| Drug Interaction |
9.5% |
| Suicidal Ideation |
9.5% |
| Tremor |
9.5% |
| Somnolence |
7.1% |
| Serotonin Syndrome |
6.0% |
| Completed Suicide |
4.8% |
| Convulsion |
4.8% |
| Loss Of Consciousness |
4.8% |
| Paraesthesia |
4.8% |
| Galactorrhoea |
3.6% |
| Maternal Exposure During Pregnancy |
3.6% |
| Multiple Drug Overdose Intentional |
3.6% |
| Pneumonia |
3.6% |
| Suicide Attempt |
3.6% |
| Tachycardia |
3.6% |
| Toxicity To Various Agents |
3.6% |
| Treatment Noncompliance |
3.6% |
| Ventricular Extrasystoles |
3.6% |
| Vomiting |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
|
| Secondary |
| Product Used For Unknown Indication |
21.5% |
| Depression |
18.9% |
| Drug Use For Unknown Indication |
14.1% |
| Drug Exposure During Pregnancy |
7.0% |
| Insomnia |
6.3% |
| Obsessive-compulsive Disorder |
6.1% |
| Major Depression |
3.8% |
| Suicide Attempt |
3.0% |
| Schizophrenia |
2.9% |
| Psychotic Disorder |
2.6% |
| Epilepsy |
2.1% |
| Pain |
1.9% |
| Intentional Overdose |
1.6% |
| Attention Deficit/hyperactivity Disorder |
1.5% |
| Bipolar I Disorder |
1.4% |
| Anxiety |
1.3% |
| Febrile Convulsion |
1.1% |
| Bipolar Disorder |
1.0% |
| Schizophrenia, Paranoid Type |
1.0% |
| Anxiety Disorder |
0.9% |
|
| Serotonin Syndrome |
11.7% |
| Completed Suicide |
9.0% |
| Suicidal Ideation |
8.3% |
| Tic |
8.3% |
| Toxicity To Various Agents |
6.2% |
| Drug Ineffective |
5.5% |
| Hypotonia Neonatal |
4.8% |
| Torsade De Pointes |
4.8% |
| Sinus Tachycardia |
4.1% |
| Treatment Noncompliance |
4.1% |
| Weight Increased |
4.1% |
| Drug Interaction |
3.4% |
| Galactorrhoea |
3.4% |
| Loss Of Consciousness |
3.4% |
| Overdose |
3.4% |
| Tendon Rupture |
3.4% |
| White Blood Cell Count Decreased |
3.4% |
| Parkinsonism |
2.8% |
| Persecutory Delusion |
2.8% |
| Sepsis |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
22.2% |
| Depression |
18.7% |
| Product Used For Unknown Indication |
9.7% |
| Insomnia |
6.5% |
| Schizophrenia |
5.5% |
| Hypertension |
4.2% |
| Anxiety |
3.5% |
| Obsessive-compulsive Disorder |
3.3% |
| Skin Ulcer |
2.8% |
| Constipation |
2.6% |
| Pain |
2.6% |
| Rheumatoid Arthritis |
2.6% |
| Diabetes Mellitus |
2.4% |
| Diffuse Large B-cell Lymphoma |
2.3% |
| Neurosis |
2.2% |
| Prophylaxis |
2.0% |
| Bipolar Disorder |
1.9% |
| Hiv Infection |
1.9% |
| Parkinson's Disease |
1.9% |
| Osteoporosis |
1.3% |
|
| Vomiting |
7.3% |
| Tremor |
6.8% |
| White Blood Cell Count Decreased |
6.3% |
| Drug Interaction |
5.8% |
| Suicidal Ideation |
5.8% |
| Suicide Attempt |
5.8% |
| Weight Increased |
5.8% |
| Granulocytopenia |
5.2% |
| Somnolence |
5.2% |
| Malaise |
4.7% |
| Pyrexia |
4.7% |
| White Blood Cell Count Increased |
4.7% |
| B-cell Lymphoma |
4.2% |
| Completed Suicide |
4.2% |
| Paranoia |
4.2% |
| Restlessness |
4.2% |
| Rhabdomyolysis |
4.2% |
| Hepatic Function Abnormal |
3.7% |
| Liver Disorder |
3.7% |
| Neuroleptic Malignant Syndrome |
3.7% |
|
| Interacting |
| Pain |
16.5% |
| Obsessive-compulsive Disorder |
15.2% |
| Depression |
8.9% |
| Drug Use For Unknown Indication |
7.0% |
| Schizophrenia |
5.7% |
| Bipolar Disorder |
5.1% |
| Gastrooesophageal Reflux Disease |
5.1% |
| Prophylaxis |
5.1% |
| Hiv Infection |
3.8% |
| Schizophrenia, Paranoid Type |
3.8% |
| Analgesic Therapy |
2.5% |
| Antidepressant Drug Level Decreased |
2.5% |
| Dysuria |
2.5% |
| Generalised Anxiety Disorder |
2.5% |
| Insomnia |
2.5% |
| Mineral Supplementation |
2.5% |
| Panic Disorder |
2.5% |
| Vitamin Supplementation |
2.5% |
| Product Used For Unknown Indication |
1.9% |
| Psychotic Disorder |
1.9% |
|
| Drug Interaction |
17.8% |
| Anxiety |
8.9% |
| Drug Ineffective |
8.9% |
| Serotonin Syndrome |
6.7% |
| Tachyphrenia |
6.7% |
| Coma |
4.4% |
| Dyskinesia |
4.4% |
| Gynaecomastia |
4.4% |
| Meige's Syndrome |
4.4% |
| Torsade De Pointes |
4.4% |
| Toxicity To Various Agents |
4.4% |
| Treatment Noncompliance |
4.4% |
| Withdrawal Syndrome |
4.4% |
| Dehydration |
2.2% |
| Discomfort |
2.2% |
| Drug Toxicity |
2.2% |
| Electrocardiogram U-wave Abnormality |
2.2% |
| Galactorrhoea |
2.2% |
| Hospitalisation |
2.2% |
| Loss Of Consciousness |
2.2% |
|
